PDB Short entry for 1IMV HEADER SIGNALING PROTEIN 11-MAY-01 1IMV TITLE 2.85 A CRYSTAL STRUCTURE OF PEDF COMPND MOL_ID: 1; COMPND 2 MOLECULE: PIGMENT EPITHELIUM-DERIVED FACTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PEDF; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: BHK; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMA KEYWDS SERPIN, PEDF, ANGIOGENESIS, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.SIMONOVIC,P.G.W.GETTINS,K.VOLZ REVDAT 8 16-AUG-23 1IMV 1 HETSYN REVDAT 7 29-JUL-20 1IMV 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE REVDAT 6 04-APR-18 1IMV 1 REMARK REVDAT 5 13-JUL-11 1IMV 1 VERSN REVDAT 4 24-FEB-09 1IMV 1 VERSN REVDAT 3 01-APR-03 1IMV 1 JRNL REVDAT 2 03-OCT-01 1IMV 1 JRNL REVDAT 1 26-SEP-01 1IMV 0 JRNL AUTH M.SIMONOVIC,P.G.GETTINS,K.VOLZ JRNL TITL CRYSTAL STRUCTURE OF HUMAN PEDF, A POTENT ANTI-ANGIOGENIC JRNL TITL 2 AND NEURITE GROWTH-PROMOTING FACTOR. JRNL REF PROC.NATL.ACAD.SCI.USA V. 98 11131 2001 JRNL REFN ISSN 0027-8424 JRNL PMID 11562499 JRNL DOI 10.1073/PNAS.211268598 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 200608.110 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.2 REMARK 3 NUMBER OF REFLECTIONS : 11241 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1167 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.03 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 65.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1166 REMARK 3 BIN R VALUE (WORKING SET) : 0.3010 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 140 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.029 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2923 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 45 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 45.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.92000 REMARK 3 B22 (A**2) : 7.44000 REMARK 3 B33 (A**2) : -3.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.43 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.47 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.250 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.190 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.840 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.980 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 36.78 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.PARAM REMARK 3 TOPOLOGY FILE 3 : WATER.PARAM REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 RESIDUES 1-15 AND 353-360 ARE MISSING/DISORDERED. REMARK 3 THE SIDE CHAINS OF THE FOLLOWING RESIDUES ARE DISORDERED: REMARK 3 THR16, ARG79, LYS126, LYS127, ARG174, LYS177, GLU178, ASP181, REMARK 3 GLU182, LYS228, THR352. REMARK 4 REMARK 4 1IMV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAY-01. REMARK 100 THE DEPOSITION ID IS D_1000013415. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-APR-01; 08-APR-01; 10-APR-01 REMARK 200 TEMPERATURE (KELVIN) : 298.0; 298.0; 298.0 REMARK 200 PH : 6.20 REMARK 200 NUMBER OF CRYSTALS USED : 3 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N; N; N REMARK 200 RADIATION SOURCE : ROTATING ANODE; ROTATING ANODE; REMARK 200 ROTATING ANODE REMARK 200 BEAMLINE : NULL; NULL; NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200; RIGAKU RU200; REMARK 200 RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418; 1.5418; 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER + MIRRORS; NI FILTER + REMARK 200 MIRRORS; NI FILTER + MIRRORS REMARK 200 OPTICS : FOCUSING MIRRORS; FOCUSING REMARK 200 MIRRORS; FOCUSING MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE; IMAGE PLATE; IMAGE REMARK 200 PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC; RIGAKU RAXIS REMARK 200 IIC; RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11214 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 36.740 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.1 REMARK 200 DATA REDUNDANCY : 12.70 REMARK 200 R MERGE (I) : 0.12700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 65.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH; SINGLE REMARK 200 WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1QLP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM FLUORIDE, 20% PEG 3350, REMARK 280 PH 6.20, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 88.08700 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.25700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 88.08700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.25700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 1 REMARK 465 PRO A 2 REMARK 465 ALA A 3 REMARK 465 SER A 4 REMARK 465 PRO A 5 REMARK 465 PRO A 6 REMARK 465 GLU A 7 REMARK 465 GLU A 8 REMARK 465 GLY A 9 REMARK 465 SER A 10 REMARK 465 PRO A 11 REMARK 465 ASP A 12 REMARK 465 PRO A 13 REMARK 465 ASP A 14 REMARK 465 SER A 15 REMARK 465 PRO A 353 REMARK 465 SER A 354 REMARK 465 PRO A 355 REMARK 465 GLY A 356 REMARK 465 LEU A 357 REMARK 465 GLN A 358 REMARK 465 PRO A 359 REMARK 465 ALA A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 16 OG1 CG2 REMARK 470 ARG A 79 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 126 CG CD CE NZ REMARK 470 LYS A 127 CG CD CE NZ REMARK 470 ARG A 174 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 177 CG CD CE NZ REMARK 470 GLU A 178 CG CD OE1 OE2 REMARK 470 ASP A 181 CG OD1 OD2 REMARK 470 GLU A 182 CG CD OE1 OE2 REMARK 470 LYS A 228 CG CD CE NZ REMARK 470 THR A 352 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 62 C - N - CA ANGL. DEV. = 9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 53 75.48 -113.74 REMARK 500 PRO A 62 -38.99 -39.00 REMARK 500 SER A 73 -4.22 -56.01 REMARK 500 GLU A 78 -81.45 -10.66 REMARK 500 ASP A 91 1.98 -66.87 REMARK 500 PRO A 96 -162.06 -75.20 REMARK 500 ASP A 97 54.83 31.43 REMARK 500 LYS A 127 7.19 50.33 REMARK 500 THR A 176 55.88 -158.61 REMARK 500 GLU A 178 110.67 69.75 REMARK 500 SER A 184 -69.64 -108.00 REMARK 500 ASP A 214 178.78 176.23 REMARK 500 ASP A 226 99.39 -161.13 REMARK 500 LEU A 273 108.42 -53.24 REMARK 500 GLU A 311 40.02 -101.68 REMARK 500 ASP A 319 -97.92 -85.34 REMARK 500 LEU A 362 121.16 74.96 REMARK 500 THR A 363 -167.53 -129.60 REMARK 500 LEU A 366 114.81 -164.00 REMARK 500 ARG A 396 -7.34 -55.57 REMARK 500 REMARK 500 REMARK: NULL DBREF 1IMV A 1 398 UNP P36955 PEDF_HUMAN 21 418 SEQRES 1 A 398 ASN PRO ALA SER PRO PRO GLU GLU GLY SER PRO ASP PRO SEQRES 2 A 398 ASP SER THR GLY ALA LEU VAL GLU GLU GLU ASP PRO PHE SEQRES 3 A 398 PHE LYS VAL PRO VAL ASN LYS LEU ALA ALA ALA VAL SER SEQRES 4 A 398 ASN PHE GLY TYR ASP LEU TYR ARG VAL ARG SER SER MET SEQRES 5 A 398 SER PRO THR THR ASN VAL LEU LEU SER PRO LEU SER VAL SEQRES 6 A 398 ALA THR ALA LEU SER ALA LEU SER LEU GLY ALA ASP GLU SEQRES 7 A 398 ARG THR GLU SER ILE ILE HIS ARG ALA LEU TYR TYR ASP SEQRES 8 A 398 LEU ILE SER SER PRO ASP ILE HIS GLY THR TYR LYS GLU SEQRES 9 A 398 LEU LEU ASP THR VAL THR ALA PRO GLN LYS ASN LEU LYS SEQRES 10 A 398 SER ALA SER ARG ILE VAL PHE GLU LYS LYS LEU ARG ILE SEQRES 11 A 398 LYS SER SER PHE VAL ALA PRO LEU GLU LYS SER TYR GLY SEQRES 12 A 398 THR ARG PRO ARG VAL LEU THR GLY ASN PRO ARG LEU ASP SEQRES 13 A 398 LEU GLN GLU ILE ASN ASN TRP VAL GLN ALA GLN MET LYS SEQRES 14 A 398 GLY LYS LEU ALA ARG SER THR LYS GLU ILE PRO ASP GLU SEQRES 15 A 398 ILE SER ILE LEU LEU LEU GLY VAL ALA HIS PHE LYS GLY SEQRES 16 A 398 GLN TRP VAL THR LYS PHE ASP SER ARG LYS THR SER LEU SEQRES 17 A 398 GLU ASP PHE TYR LEU ASP GLU GLU ARG THR VAL ARG VAL SEQRES 18 A 398 PRO MET MET SER ASP PRO LYS ALA VAL LEU ARG TYR GLY SEQRES 19 A 398 LEU ASP SER ASP LEU SER CYS LYS ILE ALA GLN LEU PRO SEQRES 20 A 398 LEU THR GLY SER MET SER ILE ILE PHE PHE LEU PRO LEU SEQRES 21 A 398 LYS VAL THR GLN ASN LEU THR LEU ILE GLU GLU SER LEU SEQRES 22 A 398 THR SER GLU PHE ILE HIS ASP ILE ASP ARG GLU LEU LYS SEQRES 23 A 398 THR VAL GLN ALA VAL LEU THR VAL PRO LYS LEU LYS LEU SEQRES 24 A 398 SER TYR GLU GLY GLU VAL THR LYS SER LEU GLN GLU MET SEQRES 25 A 398 LYS LEU GLN SER LEU PHE ASP SER PRO ASP PHE SER LYS SEQRES 26 A 398 ILE THR GLY LYS PRO ILE LYS LEU THR GLN VAL GLU HIS SEQRES 27 A 398 ARG ALA GLY PHE GLU TRP ASN GLU ASP GLY ALA GLY THR SEQRES 28 A 398 THR PRO SER PRO GLY LEU GLN PRO ALA HIS LEU THR PHE SEQRES 29 A 398 PRO LEU ASP TYR HIS LEU ASN GLN PRO PHE ILE PHE VAL SEQRES 30 A 398 LEU ARG ASP THR ASP THR GLY ALA LEU LEU PHE ILE GLY SEQRES 31 A 398 LYS ILE LEU ASP PRO ARG GLY PRO MODRES 1IMV ASN A 265 ASN GLYCOSYLATION SITE HET NAG A 401 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG C8 H15 N O6 FORMUL 3 HOH *45(H2 O) HELIX 1 1 ASP A 24 VAL A 29 1 6 HELIX 2 2 VAL A 29 SER A 53 1 25 HELIX 3 3 SER A 61 SER A 73 1 13 HELIX 4 4 LEU A 74 ALA A 76 5 3 HELIX 5 5 ASP A 77 LEU A 88 1 12 HELIX 6 6 TYR A 89 ILE A 93 5 5 HELIX 7 7 ASP A 97 THR A 110 1 14 HELIX 8 8 LYS A 131 GLY A 143 1 13 HELIX 9 9 ASN A 152 MET A 168 1 17 HELIX 10 10 ASP A 202 THR A 206 5 5 HELIX 11 11 LEU A 266 GLU A 271 1 6 HELIX 12 12 THR A 274 LEU A 285 1 12 HELIX 13 13 VAL A 305 GLU A 311 1 7 HELIX 14 14 GLN A 315 SER A 320 1 6 SHEET 1 A 4 ASP A 367 HIS A 369 0 SHEET 2 A 4 LYS A 286 PRO A 295 1 O VAL A 291 N TYR A 368 SHEET 3 A 4 THR A 218 ASP A 236 -1 N MET A 224 O VAL A 294 SHEET 4 A 4 SER A 207 TYR A 212 -1 O SER A 207 N MET A 223 SHEET 1 B 8 ASP A 367 HIS A 369 0 SHEET 2 B 8 LYS A 286 PRO A 295 1 O VAL A 291 N TYR A 368 SHEET 3 B 8 THR A 218 ASP A 236 -1 N MET A 224 O VAL A 294 SHEET 4 B 8 CYS A 241 LEU A 248 -1 O CYS A 241 N ASP A 236 SHEET 5 B 8 MET A 252 PRO A 259 -1 O MET A 252 N LEU A 248 SHEET 6 B 8 PHE A 374 ASP A 380 -1 O ILE A 375 N PHE A 257 SHEET 7 B 8 LEU A 386 ILE A 392 -1 N LEU A 387 O LEU A 378 SHEET 8 B 8 VAL A 58 LEU A 60 -1 N VAL A 58 O LYS A 391 SHEET 1 C 5 ARG A 147 VAL A 148 0 SHEET 2 C 5 LEU A 116 PHE A 124 1 O ILE A 122 N ARG A 147 SHEET 3 C 5 ILE A 185 LYS A 194 -1 O LEU A 186 N VAL A 123 SHEET 4 C 5 LEU A 333 TRP A 344 1 N THR A 334 O ILE A 185 SHEET 5 C 5 LEU A 297 GLU A 304 -1 O LEU A 297 N TRP A 344 SHEET 1 D 2 TRP A 197 THR A 199 0 SHEET 2 D 2 GLY A 348 GLY A 350 1 N ALA A 349 O TRP A 197 LINK ND2 ASN A 265 C1 NAG A 401 1555 1555 1.45 CRYST1 176.174 62.514 45.406 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005676 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015996 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022024 0.00000